Co-Authors
This is a "connection" page, showing publications co-authored by Bruce Barton and Laura Alonso.
Connection Strength
0.740
-
Nwosu BU, Parajuli S, Jasmin G, Fleshman J, Sharma RB, Alonso LC, Lee AF, Barton BA. Ergocalciferol in New-onset Type 1 Diabetes: A Randomized Controlled Trial. J Endocr Soc. 2022 Jan 01; 6(1):bvab179.
Score: 0.242
-
Nwosu BU, Yeasmin S, Ayyoub S, Rupendu S, Villalobos-Ortiz TR, Jasmin G, Parajuli S, Zahedi B, Zitek-Morrison E, Alonso LC, Barton BA. Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes. J Pediatr Endocrinol Metab. 2020 Jul 28; 33(7):865-872.
Score: 0.220
-
Nwosu BU, Zhang B, Ayyoub SS, Choi S, Villalobos-Ortiz TR, Alonso LC, Barton BA. Children with type 1 diabetes who experienced a honeymoon phase had significantly lower LDL cholesterol 5 years after diagnosis. PLoS One. 2018; 13(5):e0196912.
Score: 0.189
-
Lundberg RL, Marino KR, Jasrotia A, Maranda LS, Barton BA, Alonso LC, Nwosu BU. Partial clinical remission in type 1 diabetes: a comparison of the accuracy of total daily dose of insulin of <0.3 units/kg/day to the gold standard insulin-dose adjusted hemoglobin A1c of ?9 for the detection of partial clinical remission. J Pediatr Endocrinol Metab. 2017 Aug 28; 30(8):823-830.
Score: 0.045
-
Marino KR, Lundberg RL, Jasrotia A, Maranda LS, Thompson MJ, Barton BA, Alonso LC, Nwosu BU. A predictive model for lack of partial clinical remission in new-onset pediatric type 1 diabetes. PLoS One. 2017; 12(5):e0176860.
Score: 0.044